Needham & Company
View Older Stories
-
UPDATE: Needham & Company Downgrades Boston Scientific (BSX) to Buy, Off Conviction List
-
Boston Scientific (BSX) PT Raised to 'Street High' $53 at Needham & Company Amid Completion of BTG Deal
-
Boston Scientific (BSX) Likely to Lower Guidance - Needham & Company
-
Boston Scientific (BSX) Is Paying A High Price For Unproven Millipede - Needham
-
Boston Scientific (BSX) Top Rating Maintained at Needham & Company Despite Mixed Qtr
-
Boston Scientific (BSX) PT Raised to $39 at Needham & Company
-
Boston Scientific (BSX) PT Raised to $36 at Needham & Company
-
Boston Scientific to Participate in 17th Annual Needham Healthcare Conference
-
Boston Scientific (BSX) PT Raised to $35 at Needham & Company
-
Needham & Company Upgrades Boston Scientific (BSX) to Strong Buy, Strong Product Cycle Should Drive Relative Outperformance, 2018 Street Estimates Are Conservative
-
UPDATE: Boston Scientific (BSX) Falls to Low After Canceling Out of Conference
-
Abbott profit forecast gets a lift from St. Jude integration
-
Boston Scientific (BSX): 3 Takeaways From Management Meetings - Needham
-
Boston Scientific (BSX) PT Raised to $30 at Needham & Company
-
Boston Scientific (BSX) PT Raised to $29 at Needham & Company Following 4Q Report
-
Unusual 11 Mid-Day Movers 12/13: (USEG) (GLF) (AKAO) Higher; (PRTO) (INOV) (LIFE) Lower (more...)
-
Pre-Open Stock Movers 12/13: (NVCN) (AKAO) (SCYX) Higher; (PRTO) (INOV) (BDSI) Lower (more...)
-
Boston Scientific (BSX) PT Raised to $28 at Needham & Company
-
ResMed (RMD), St. Jude (STJ), Cepheid (CPHD) Among Med Tech Companies with Most EU Exposure - Needham & Company
-
Boston Scientific (BSX) PT Raised to $26 at Needham & Company
-
Boston Scientific To Participate In 15th Annual Needham Healthcare Conference
-
Analysts Comment on Boston Scientific (BSX) and CMS Proposed Restrictions on Watchman Coverage
-
Boston Scientific (BSX) Reports Strong 3Q Results; Needham & Company Reiterates Buy
-
Needham & Company Upgrades Boston Scientific (BSX) to Buy
-
Notable Analyst Rating Changes 3/20: (OC) (HON) (AUY) Upgraded; (CCG) (EXTR) (UCTT) Downgraded
-
Needham & Company Starts Boston Scientific (BSX) at Hold
-
Notable Analyst Rating Changes 01/21: (BSX) (STX) (ALTR) Upgraded; (DDD) (AAPL) (SCTY) Downgraded
-
Notable Analyst Rating Changes 07/08: (BBRY) (LINE) (PGNX) Upgraded; (SSRI) (BSX) (INTC) Downgraded
-
StreetInsider.com Pre-Open Movers 12/3: (SVU) (DECK) (DELL) Higher; (MYGN) (HMA) (RIMM) Lower (more...)
-
Notable Analyst Rating Changes 11/04: KIM, PHM, QCOM, HMA Upgraded; MPWR, PT, SWIR, K Downgraded
-
Morning Movers 4/16: PFWD, LGF, IMGN, PNK, BSX Higher; ABK, FHN, GOOG, AMD Lower
-
After-Hours Movers 4/15: LGF, BSX, SIMO Higher; NPSP, GOOG, AMD, HNSN Lower
-
Notable Analyst Rating Changes 6/16: TEL, SUNH, COOL, SMOD Upgraded; T, CX, TWTC, FTO Downgraded
-
Needham & Co Reiterates a 'Buy' on Given Imaging (GIVN); Could be Attractive Acquisition Target